PRAME and hepatocellular carcinoma: In preliminary experiments, viable outgrowing clones could not be generated from CRISPR-mediated full knockout of PRAME in MEL624 cells (data not shown), consistent with literature that PRAME inhibition causes cell cycle arrest and apoptosis in leukemic and hepatocellular carcinoma cells [10, 47].